**Question:** Major metabolite of noradrenaline in urine is:

A. Methoxyhydroxylamine
B. Homovanillic Acid
C. 3-methoxy-4-hydroxyphenylglycol
D. Vanillylmandelic Acid

**Core Concept:**
Noradrenaline (norepinephrine) is a catecholamine neurotransmitter and hormone. After being released from neurons or synthesized in the adrenal glands, noradrenaline is rapidly converted to different chemical substances through enzymatic processes. The major product of noradrenaline breakdown in urine is considered the key focus of this question.

**Why the Correct Answer is Right:**
The correct answer, **D. Vanillylmandelic Acid (VMA)**, is the major urinary excreted product arising from the enzymatic breakdown of noradrenaline. In the catecholamine pathway, noradrenaline is broken down by the enzyme catechol-O-methyltransferase (COMT) into dopamine, followed by monoamine oxidase (MAO) into VMA, which is then converted into vanillylmandelic acid.

**Why Each Wrong Option is Incorrect:**
A. **Methoxyhydroxylamine (A)** is a wrong answer because it is a byproduct of dopamine rather than noradrenaline. Methoxyhydroxylamine is formed from the oxidation of dopamine by monoamine oxidase (MAO).
B. **Homovanillic Acid (B)** is incorrect because it is a byproduct of dopamine, not noradrenaline. Homovanillic acid is formed from the oxidation of dopamine by monoamine oxidase (MAO).
C. **3-Methoxy-4-hydroxyphenylglycol (C)** is a wrong answer because it is a byproduct of norepinephrine (epinephrine), not noradrenaline. 3-methoxy-4-hydroxyphenylglycol is formed from the oxidation of norepinephrine by monoamine oxidase (MAO).

**Clinical Pearl:**
Monoamine oxidase (MAO) is an important enzyme found in the liver and intestinal mucosa that plays a crucial role in the catabolism of catecholamines (noradrenaline, dopamine, and epinephrine). Understanding the correct breakdown products and their clinical correlations can aid in differentiating between catecholamine deficiencies and excesses in clinical scenarios.

**Correct Answer Explanation:**
Vanillylmandelic acid (VMA) is the major urinary excreted product following the breakdown of noradrenaline by monoamine oxidase (MAO). VMA is a useful biomarker for diagnosing and monitoring the effectiveness of treatment in patients with pheochromocytoma, a rare tumor in the adrenal medulla that overproduces catecholamines. Elevated urinary VMA levels are indicative of excessive production of noradrenaline and can help in the diagnosis of pheochromocytoma and/or other conditions that cause noradrenaline overproduction like